Press-release for stocks

Prices are updated after-hours

meeting crawled time : 14:30

save search

Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-05 (Crawled : 14:30) - biospace.com/
IMNM | $14.515 -0.99% 130K

Health Technology

| -27.64% | O: -0.44% H: 3.37% C: 0.45%
im-3050 association cancer research preclinical for meeting therapy

DoubleDown Interactive Announces Results of 2024 Annual General Meeting
Published: 2024-03-29 (Crawled : 14:30) - globenewswire.com
DDI | $10.58 -7.36% 6K

Consumer Services

| Email alert Add to watchlist
meeting

Notice of Annual General Meeting in ASSA ABLOY AB
Published: 2024-03-20 (Crawled : 14:30) - prnewswire.com
ASAZY | $14.38 160K

Construction

| -1.3% | O: 0.82% H: 1.63% C: 1.57%
meeting

COFFEE HOLDING CO., INC. ANNOUNCES SPECIAL MEETING OF STOCKHOLDERS TO VOTE ON PROPOSED BUSINESS COMBINATION WITH DELTA CORP HOLDINGS LIMITED; FORM F-4 DECLARED EFFECTIVE
Published: 2024-03-07 (Crawled : 14:30) - globenewswire.com
JVA | $1.77 4.73% 26K

Consumer Non-Durables

| 26.12% | O: 0.0% H: 2.99% C: 0.0%
business meeting

Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
Published: 2024-03-07 (Crawled : 14:30) - globenewswire.com
CYCC | $1.95 8.94% 39K

Health Technology

| -24.47% | O: 12.24% H: 0.0% C: -6.39%
association cancer pharmaceuticals research preclinical meeting

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
HBIO | $3.72 3.4K

Health Technology

| -11.22% | O: 1.67% H: 3.48% C: -3.52%
bioscience preclinical solutions meeting

Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
NVNO | $5.17 -6.0% 52K

Manufacturing

| -14.2% | O: 2.96% H: 3.48% C: -9.7%
enous2024 positive topline meeting trial today

Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve® Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
Published: 2024-03-06 (Crawled : 14:30) - hancockjaffe.com
NVNO | $5.17 -6.0% 52K

Manufacturing

| -14.2% | O: 2.96% H: 3.48% C: -9.7%
enous2024 venovalve positive topline meeting trial today

Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting
Published: 2024-03-05 (Crawled : 14:30) - globenewswire.com
MMSI | $73.83 -0.47% 30K

Health Technology

| -3.05% | O: 0.13% H: 0.31% C: -1.96%
innovation meeting medical

New Data from Incyte’s Growing Dermatology Portfolio to be Presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting
Published: 2024-03-04 (Crawled : 14:30) - biospace.com/
INCY | $51.27 -0.74% 170K

Health Technology

| -12.53% | O: 0.34% H: 0.89% C: 0.79%
meeting growing

Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy
Published: 2024-02-27 (Crawled : 13:30) - globenewswire.com
CAPR | $5.19 7.68% 600K

Health Technology

| 21.72% | O: 2.53% H: 13.6% C: 6.9%
cap-1002 fda meeting commercial therapeutics duchenne type-b meeting

Ecopetrol publishes measures to guarantee the adequate representation of its Shareholders at the Ordinary General Shareholders' Meeting to be held on March 22, 2024.
Published: 2024-02-15 (Crawled : 14:30) - prnewswire.com
EC | $11.685 -0.38% 340K

Energy Minerals

| 0.6% | O: -0.17% H: 2.15% C: 1.63%
meeting

YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.
Published: 2024-02-12 (Crawled : 14:30) - biospace.com/
YS | $0.8109 4.8K

n/a

| 93.32% | O: 7.4% H: 0.0% C: -9.38%
biopharma meeting

New Intermediate Nail and RC Lag Screw Expand Gamma4 Portfolio to Meet the Needs of Surgeons and Their Patients
Published: 2024-01-17 (Crawled : 14:30) - biospace.com/
SYK | $337.47 0.76% 530K

Health Technology

| 6.56% | O: -0.48% H: 0.73% C: 0.28%

Hollysys Announces Shareholder Meeting to Vote on Acquisition by Ascendent Capital Partners
Published: 2024-01-05 (Crawled : 14:30) - prnewswire.com
HOLI | $24.48 0.33% 7.3K

Electronic Technology

| -6.33% | O: 0.58% H: 1.47% C: 0.95%
acquisition meeting

Hollysys Announces Shareholder Meeting to Vote on Acquisition by … – PR Newswire
Published: 2024-01-05 (Crawled : 14:30) - spacfeed.com
CPT 4 | $98.98 0.39% 140K

Finance

| 0.81% | O: -0.81% H: 1.72% C: 1.21%
acquisition meeting

Coya Therapeutics Announces Successful Pre-IND and Type C Meetings with the FDA to Advance the Development of COYA 302 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
Published: 2024-01-05 (Crawled : 14:30) - biospace.com/
COYA | News | $8.72 8.73% 89K

| 19.88% | O: 1.94% H: 2.79% C: 0.0%
fda sclerosis treatment therapeutics

Borr Drilling Limited - Special General Meeting Results Notification
Published: 2023-12-22 (Crawled : 14:30) - prnewswire.com
BORR | $5.61 -2.77% 670K

Industrial Services